Post-transcriptional regulation of plasminogen activator inhibitor-1 by intracellular iron in cultured human lung fibroblasts - Interaction of an 81-kDa nuclear protein with the 3′-UTR

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 5, 2005, Pages 1001-1008

  Radha, K S ^a   Sugiki, M ^a   Kumar, M Harish ^a   Omura, S ^a   Maruyama, M ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Cell surface plasmin activity; Fibroblasts; Iron depletion; mRNA binding protein; PAI 1; Post transcriptional

Indexed keywords

DEFEROXAMINE; FERRIC CITRATE; IRON; NUCLEAR PROTEIN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; ANTIGEN; CROSS LINKING REAGENT; CYCLOHEXIMIDE; FERRIC ION; MESSENGER RNA;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LUNG FIBROBLAST; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; CELL CULTURE; CELL MEMBRANE; CELL NUCLEUS; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; CYTOPLASM; FIBROBLAST; GENETIC TRANSCRIPTION; GENETICS; LUNG; METABOLISM; PLASMID; RNA PROCESSING; TIME; ULTRAVIOLET RADIATION; WOUND HEALING;

3' UNTRANSLATED REGIONS; ANTIGENS; BLOTTING, NORTHERN; CELL MEMBRANE; CELL NUCLEUS; CELLS, CULTURED; CROSS-LINKING REAGENTS; CULTURE MEDIA, CONDITIONED; CYCLOHEXIMIDE; CYTOPLASM; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FERRIC COMPOUNDS; FIBROBLASTS; HUMANS; IRON; LUNG; PLASMIDS; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BIOSYNTHESIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; ULTRAVIOLET RAYS; WOUND HEALING;

EID: 23844435017     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01272.x     Document Type: Article

References (57)

1. Rerolle J-P, Hertig A, Nguyen G, Sraer J-D, Rondeau EP. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 2000; 58: 1841-50.
2. Chan JCY, Duszczyszyn DA, Castellino FJ, Ploplis VA. Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am J Pathol 2001; 159: 1681-8.
3. Hagood JS, Olman MA, Godoy JA, Rivera KE, Fuller GM. Regulation of type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts. Blood 1996; 87: 3749-57.
4. Andrew A, Barchowsky A. Nickel-induced plasminogen activator inhibitor-1 expression inhibits the fibrinolytic activity of human airway epithelial cells. Toxicol Appl Pharmacol 2000; 168: 50-7.
5. Gardi C, Arezzini B, Fortino V, Comporti M. Effect of free iron on collagen synthesis, cell proliferation and MMP-2 expression in rat hepatic stellate cells. Biochem Pharmacol 2002; 64: 1139-45.
6. Wenk J, Foitzik A, Achterberg V, Sabiwalsky A, Dissemond J, Meewes C, Reitz A, Brenneisen P, Wlaschek M, Meyer-Ingold W, Scharffetter-Kochanek K. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol 2001; 116: 833-9.
7. Yoshida E, Ohmura S, Sugiki M, Anai K, Maruyama M. A novel function of extraerythrocytic hemoglobin: identification of globin as a stimulant of plasminogen activator biosynthesis in human fibroblasts. Thromb Haemost 2001; 86: 1521-7.
8. Mattia E, den Blaauwen J, Ashwell G, van Renswoude J. Multiple post-transcriptional regulatory mechanisms in ferritin gene expression. Proc Natl Acad Sci USA 1989; 86: 1801-5.
9. Tanji K, Imaizumi T, Matsumiya T, Itaya H, Fujimoto K, Cui X, Toki T, Ito E, Yoshida H, Wakabayashi K, Satoh K. Desferriox-amine, an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line. Biochim Biophys Acta 2001; 1530: 227-35.
10. Ye Z, Connor JR. Screening of transcriptionally regulated genes following iron chelation in human astrocytoma cells. Biochem Biophys Res Commun 1999; 264: 709-13.
11. Beerepoot LV, Shima DT, Kuroki M, Yeo KT, Voest EE. Up-regulation of vascular endothelial growth factor production by iron chelators. Cancer Res 1996; 56: 3747-51.
12. Templeton DM, Liu Y. Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta 2003; 1619: 113-24.
13. Dignam JD, Martin PL, Shastry BS, Roeder RG. Eukaryotic gene transcription with purified components. Methods Enzymol 1983; 101: 582-98.
14. Stephens RW, Pollanen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, Ronne E, Behrendt N, Dano K, Vaheri A. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol 1989; 108: 1987-95.
15. Ryan MP, Kutz SM, Higgins PJ. Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion. Biochem J 1996; 314: 1041-6.
16. Arts J, Grimbergen J, Toet K, Kooistra T. On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1{alpha} in HepG2 cells. Arterioscler Thromb Vasc Biol 1999; 19: 39-46.
17. Rao K, Harford JB, Rouault T, McClelland A, Ruddle FH, Klausner RD. Transcriptional regulation by iron of the gene for the transferrin receptor. Mol Cell Biol 1986; 6: 236-40.
18. Goto Y, Paterson M, Listowsky I. Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free media. J Biol Chem 1983; 258: 5248-55.
19. Voest EE, Rooth H, Neijt JP, van Asbeck BS, Marx JJ. The in vitro response of human tumour cells to desferrioxamine is growth medium dependent. Cell Prolif 1993; 26: 77-88.
20. West MD, Shay JW, Wright WE, Linskens MH. Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp Gerontol 1996; 31: 175-93.
21. Mu XC, Staiano-Coico L, Higgins PJ. Increased transcription and modified growth state-dependent expression of the plasminogen activator inhibitor type-1 gene characterize the senescent phenotype in human diploid fibroblasts. J Cell Physiol 1998; 174: 90-8.
22. Rouault TA. Post-transcriptional regulation of human iron metabolism by iron regulatory proteins. Blood Cells Mol Dis 2002; 29: 309-14.
23. Pepper MS. Extracellular proteolysis and angiogenesis. Thromb Haemost 2001; 86: 346-55.
24. van Meijer M, Pannekoek H. Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update. Fibrinolysis 1995; 9: 263-76.
25. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999; 56: 104-32.
26. Heaton JH, Dlakic WM, Dlakic M, Gelehrter TD. Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the type-1 plasminogen activator inhibitor mRNA. J Biol Chem 2001; 276: 3341-7.
27. Shetty S, Bdeir K, Cines DB, Idell S. Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem 2003; 278: 18124-31.
28. Sandier M, Zhang J, Westerhausen D Jr, Billadello J. A novel protein interacts with the major transforming growth factor-beta responsive element in the plasminogen activator inhibitor type-1 gene. J Biol Chem 1994; 69: 21500-4.
29. Hasegawa T, Sorensen L, Ooi H, Marshall BC. Decreased intracellular iron availability suppresses epithelial cell surface plasmin generation. Transcriptional and post-transcriptional effects on u-PA and PAI-1 expression. Am J Respir Cell Mol Biol 1999; 21: 275-82.
30. Yeh LC, Mikhailov V, Lee JC. Regulation of expression of plasminogen activator inhibitor-1 in cultured rat osteoblastic cells by osteogenic protein-1 (BMP-7). J Cell Biochem 2001; 81: 46-54.
31. Horton MR, Olman MA, Bao C, White KE, Choi AMK, Chin B-Y, Noble PW, Lowenstein CJ. Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol 2000; 279: L707-15.
32. Bosnia PJ, Kooistra T. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells. J Biol Chem 1991; 266: 17845-9.
33. Fattal P, Schneider D, Sobel B, Billadello J. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1. J Biol Chem 1992; 267: 12412-5.
34. Faa GCG. Iron chelating agents in clinical practice. Coordination Chem Rev 1999; 184: 291-310.
35. Cazzola M, Bergamaschi G, Dezza L, Arosio P. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects. Blood 1990; 75: 1903-19.
36. Rothman RJ, Serroni A, Farber JL. Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol Pharmacol 1992; 42: 703-10.
37. Fast B, Kremp K, Boshart M, Steverding D. Iron-dependent regulation of transferrin receptor expression in Trypanosoma brucei. Biochem J 1999; 342: 691-6.
38. Martelin E, Lapatto R, Raivio KO. Regulation of xanthine oxidoreductase by intracellular iron. Am J Physiol Cell Physiol 2002; 283: C1722-8.
39. Hoepken HH, Korten T, Robinson SR, Dringen R. Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J Neurochem 2004; 88: 1194-202.
40. Yankulov K, Yamashita K, Roy R, Egly J-M, Bentley DL. The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuran-osylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J Biol Chem 1995; 270: 23922-5.
41. Posch M, Sutterluety H, Skern T, Seiser C. Characterization of the translation-dependent step during iron-regulated decay of transferrin receptor mRNA. J Biol Chem 1999; 274: 16611-8.
42. Mayer M, Lund LR, Riccio A, Skouv J, Nielsen LS, Stacey SN, Dano K, Andreasen PA. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells. J Biol Chem 1988; 263: 15688-93.
43. van den Berg EA, Sprengers ED, Jaye M, Burgess W, Maciag T, van Hinsbergh VW. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb Haemost 1988; 60: 63-7.
44. Shetty S, Well S. Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro. Am J Physiol Lung Cell Mol Physiol 2000; 278: L148-56.
45. Koeller DM, Horowitz JA, Casey JL, Klausner RD, Harford JB. Translation and the stability of mRNAs encoding the transferrin receptor and c-fos. Proc Natl Acad Sci USA 1991; 88: 7778-82.
46. Ross J. mRNA stability in mammalian cells. Microbiol Rev 1995; 59: 423-50.
47. Leibold EA, Munro HN. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5' untranslated region of ferritin heavy- and light-subunit mRNAs. Proc Natl Acad Sci USA 1988; 85: 2171-5.
48. Shih SC, Claffey KP. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J Biol Chem 1999; 274: 1359-65.
49. Rajagopalan LE, Westmark CJ, Jarzembowsk JA, Maker JS. hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA. Nucl Acids Res 1998; 26: 3418-23.
50. Kiledjian M, DeMaria CT, Brewer G, Novick K. Identification of AUF 1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex. Mol Cell Biol 1997; 17: 4870-6.
51. Zaidi SH, Malter JS. Nucleolin and heterogeneous nuclear ribonucleoprotein C proteins specifically interact with the 3′- untranslated region of amyloid protein precursor mRNA. J Biol Chem 1995; 270: 17292-8.
52. Shetty S. Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability. Mol Cell Biochem 2002; 237: 55-67.
53. Klausner RD, Harford JB. Cis-trans models for post-transcriptional gene regulation. Science 1989; 246: 870-2.
54. Henderson BR, Menotti E, Kuhn LC. Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences. J Biol Chem 1996; 271: 4900-8.
55. Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, Klausner RD, Harford JB. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 1988; 240: 924-8.
56. Menotti E, Henderson BR, Kuhn LC. Translational regulation of mRNAs with distinct IRE sequences by iron regulatory proteins 1 and 2. J Biol Chem 1998; 273: 1821-4.
57. Erlitzki R, Long JC, Theil EC. Multiple, conserved iron-responsive elements in the 3′-untranslated region of transferrin receptor mRNA enhance binding of iron regulatory protein 2. J Biol Chem 2002; 277: 42579-87.